Enhancing <i>Candida auris</i> diagnosis: a comprehensive evaluation of VIASURE <i>Candida auris</i> real-time PCR detection kit for rapid diagnostic responses

<i>Candida auris</i>, a resilient and antifungal-resistant yeast, poses a significant healthcare threat due to its rapid spread. A recent outbreak at a hospital in Zaragoza, Spain, emphasized the urgent need for faster diagnostics. The current four-day wait for culture results hampers timely patient isolation. This retrospective and comparative study demonstrates the favorable clinical parameters of a commercially available molecular diagnostic kit. The kit allows enhanced diagnostic efficiency, swifter patient isolation, and more effective control measures in the laboratory. In conclusion, the kit addresses the pressing challenges presented by <i>C. auris</i> in healthcare.